Objective To evaluate whether rituximab at a low dose of 250 mg/m 2× 2 may be as effective
as at higher dosages, most commonly 375 mg/m 2× 4, used in previous studies on the …

A 5-years multicenter prospective study on 201 patients with common variable
immunodeficiencies and 101 patients with X-linked agammaglobulinemia over a cumulative …

Eradication of hepatitis C virus (HCV) by antiviral therapy is the treatment of choice for mixed
cryoglobulinemia secondary to this infection, but many patients fail to achieve sustained viral …

Hepatitis C virus (HCV)‐associated mixed cryoglobulinemia (MC) vasculitis commonly
regresses upon virus eradication, but conventional therapy with pegylated interferon and …

Cryoglobulinemic vasculitis (CV) or mixed cryoglobulinemic syndrome (MCS) is a systemic
small-vessel vasculitis characterized by the proliferation of B-cell clones producing …

We describe 2 brothers with a malformation syndrome consisting of agenesis of the corpus
callosum, cutaneous hypopigmentation, bilateral cataract, cleft lip and palate, and combined …

Chronic hepatitis C virus infection causes B cell lymphoproliferative disorders that include
type II mixed cryoglobulinemia and lymphoma. This virus drives the monoclonal expansion …

OBJECTIVE: Involvement of the central nervous system (CNS) in patients with hepatitis C
virus (HCV) mixed cryoglobulinemia (MC) is rare. The mechanism by which brain lesions …

Ataxia telangiectasia (AT), a genetic disorder caused by the homozygous mutation of the
ATM gene, frequently associates with variable degrees of cellular and humoral …

Abstract Background & Aims Hepatitis C virus (HCV)‐related mixed cryoglobulinaemia
vasculitis (MCV) is characterized by the expansion of rheumatoid factor‐producing B‐cell …